Dudediligence.

Greenland Mines Ltd

GRMLNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

158.9M

on 2026-06-30, from 3.40M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2025-07-07. Not read yet. S-3 ↗

$50.0M

Agreement of 2026-08-24. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-17 is not read yet.

Cash

2.6 quarters

$9.3M on 2026-06-30 ÷ $3.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-09-28Registered direct offering1,320,000not readnot read8-K ↗
2026-09-28Registered direct offering1,320,000$13.00not read424B5 ↗
2026-09-23Registered direct offering incl. 1.43M pre-funded3,200,000$12.00not read424B5 ↗
2026-08-26Public offering4,000,000$5.00$20.0M424B5 ↗
2026-06-25Private placement15,000,000not read$3.8M8-K ↗